GB9811622D0 - Drug formulation - Google Patents

Drug formulation

Info

Publication number
GB9811622D0
GB9811622D0 GBGB9811622.1A GB9811622A GB9811622D0 GB 9811622 D0 GB9811622 D0 GB 9811622D0 GB 9811622 A GB9811622 A GB 9811622A GB 9811622 D0 GB9811622 D0 GB 9811622D0
Authority
GB
United Kingdom
Prior art keywords
drug formulation
formulation
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9811622.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Priority to GBGB9811622.1A priority Critical patent/GB9811622D0/en
Publication of GB9811622D0 publication Critical patent/GB9811622D0/en
Ceased legal-status Critical Current

Links

GBGB9811622.1A 1998-05-29 1998-05-29 Drug formulation Ceased GB9811622D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9811622.1A GB9811622D0 (en) 1998-05-29 1998-05-29 Drug formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9811622.1A GB9811622D0 (en) 1998-05-29 1998-05-29 Drug formulation

Publications (1)

Publication Number Publication Date
GB9811622D0 true GB9811622D0 (en) 1998-07-29

Family

ID=10832947

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9811622.1A Ceased GB9811622D0 (en) 1998-05-29 1998-05-29 Drug formulation

Country Status (1)

Country Link
GB (1) GB9811622D0 (en)

Similar Documents

Publication Publication Date Title
HK1041224A1 (en) New pharmaceutical formulation
SG79255A1 (en) Pharmaceutical formulations
ZA982872B (en) Pharmaceutical formulation
EG24226A (en) Formulation
GB9905898D0 (en) Controlled-dose formulation
GB9902304D0 (en) Formulation
GB9818927D0 (en) Pharmaceutical formulation
GB9709739D0 (en) Pharmaceutical formulation
GB9909154D0 (en) Pharmaceutical formulation
GB9822333D0 (en) Pharmaceutical formulation
GB9817470D0 (en) Pharmaceutical formulation
GB9926251D0 (en) Pharmaceutical formulation
ZA994697B (en) Pharmaceutical formulation.
GB9802617D0 (en) Pharmaceutical formulation
GB9811622D0 (en) Drug formulation
GB9928489D0 (en) Pharmaceutical formulation
GB9824502D0 (en) Pharmaceutical formulation
GB9817217D0 (en) Pharmaceutical formulation
GB9902236D0 (en) Formulation
ZA997229B (en) Medicinal formulation.
GB9917775D0 (en) Pharmaceutical formulation
GB9930878D0 (en) Pharmaceutical formulation
GB9917777D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation
GB9917774D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)